Genmab A/S (GNMSF) SEC Filings — 2025

Filings

• Genmab A/S Files 6-K, Incorporates by Reference — 6-K · Dec 29, 2025
• Genmab A/S Files 6-K, Incorporates by Reference — 6-K · Dec 12, 2025
• Genmab A/S Files 6-K on Share Transactions — 6-K · Dec 1, 2025
• Genmab A/S Files 6-K, Incorporates Updates into S-8 Filings — 6-K · Nov 26, 2025
• Genmab Grants Stock Units and Warrants to Employees — 6-K · Nov 20, 2025
• Genmab A/S Files Form 6-K with Updated Articles of Association — 6-K · Nov 19, 2025
• Genmab A/S Files 6-K, Incorporates by Reference — 6-K · Nov 18, 2025
• Genmab A/S 6-K Filing — 6-K · Nov 12, 2025
• Genmab A/S 6-K Filing — 6-K · Nov 6, 2025
• Genmab Reports Strong DARZALEX® Q3 Sales — 6-K · Oct 17, 2025
• Genmab A/S Files 6-K, Incorporates Articles of Association — 6-K · Sep 30, 2025
• Genmab to Acquire Merus for $1.5B — 6-K · Sep 29, 2025
• Genmab Grants Stock Units and Warrants to Employees — 6-K · Sep 26, 2025
• Genmab A/S Files 6-K: Major Shareholder Announcement — 6-K · Sep 23, 2025
• Genmab A/S Files 6-K, Incorporates into S-8 Filings — 6-K · Sep 10, 2025
• Genmab A/S Capital Increase from Employee Warrant Exercise — 6-K · Sep 9, 2025
• Genmab A/S Files 6-K, Incorporates Articles of Association — 6-K · Aug 13, 2025
• Genmab A/S Reports Capital Increase from Warrant Exercise — 6-K · Aug 12, 2025
• Genmab's EPCORE Trial Hits Key Endpoints in DLBCL Study — 6-K · Aug 7, 2025
• Genmab Reports Strong DARZALEX® Sales for Q2 2025 — 6-K · Jul 16, 2025
• Genmab Completes Share Buy-back Program — 6-K · Jun 30, 2025
• Genmab A/S Announces Share Buy-back Program Transactions — 6-K · Jun 23, 2025
• Genmab A/S Files 6-K with Updated Articles of Association — 6-K · Jun 18, 2025
• Genmab A/S Files 6-K on Share Transactions — 6-K · Jun 17, 2025
• Genmab Buys Back 1M Shares for DKK 230M — 6-K · Jun 16, 2025
• Genmab A/S Grants Stock Units and Warrants to Employees — 6-K · Jun 12, 2025
• Genmab A/S Announces Share Buy-back Program Update — 6-K · Jun 10, 2025
• Genmab A/S Files 6-K on Share Buy-back Program — 6-K · Jun 2, 2025
• Genmab A/S Announces Share Buy-back Program Transactions — 6-K · May 27, 2025
• Genmab A/S Files 6-K, Incorporates into S-8 Filings — 6-K · May 21, 2025
• Genmab Announces Capital Increase From Warrant Exercise — 6-K · May 20, 2025
• Genmab Completes DKK 2.5B Share Buy-back — 6-K · May 19, 2025
• Genmab Buys Back Shares Worth DKK 250M — 6-K · May 12, 2025
• Genmab A/S Files 6-K with Interim Report — 6-K · May 8, 2025
• Genmab Buys Back Shares Worth DKK 2.4B — 6-K · May 5, 2025
• Genmab to File sBLA for Epcoritamab with FDA — 6-K · May 2, 2025
• Genmab Completes DKK 2.5B Share Buy-back — 6-K · Apr 28, 2025
• Genmab A/S Files Form 6-K for April 2025 — 6-K · Apr 22, 2025
• Genmab A/S Files 6-K, Incorporates into S-8 Filings — 6-K · Apr 15, 2025
• Genmab A/S Files Form 6-K for April 2025 — 6-K · Apr 14, 2025
• Genmab A/S Files 6-K, Incorporates into S-8 Filings — 6-K · Apr 10, 2025
• Genmab A/S Files Form 6-K for April 2025 — 6-K · Apr 7, 2025
• Genmab A/S Files April 2025 6-K Report — 6-K · Apr 1, 2025
• Genmab A/S Files March 2025 6-K Report — 6-K · Mar 31, 2025
• Genmab A/S Files March 2025 6-K Report — 6-K · Mar 25, 2025
• Genmab A/S Files 6-K Report — 6-K · Mar 24, 2025
• Genmab A/S Files March 2025 6-K Report — 6-K · Mar 20, 2025
• Genmab A/S Files March 2025 6-K Report — 6-K · Mar 12, 2025
• Genmab A/S Files March 2025 6-K Report — 6-K · Mar 10, 2025
• Genmab A/S Files Form 6-K for March 2025 — 6-K · Mar 6, 2025